Vimarsana
Biggest News Aggregation in the World

Jiyang Yu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jiyang Yu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jiyang Yu Today - Breaking & Trending Today

Novel therapeutic approach identified for overcoming resistance in B-cell leukemia - Vimarsana News

Novel therapeutic approach identified for overcoming resistance in B-cell leukemia

Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between 30-50%.

Success of Gene Therapy Relies on Integration Location in DNA - Vimarsana News

Success of Gene Therapy Relies on Integration Location in DNA

The location of integration of a gene therapy has been crucial for the safety and efficacy of the treatment to cure infants with X-linked severe combined immunodeficiency.

Source: ajmc.com
A subset of CD8+ T cells can play a protective role against Alzheimer's disease pathogenesis - Vimarsana News

A subset of CD8+ T cells can play a protective role against Alzheimer's disease pathogenesis

Scientists at St. Jude Children’s Research Hospital found that a subset of CD8+ T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer’s disease.

St. Jude tool gets more out of multi-omics da - Vimarsana News

St. Jude tool gets more out of multi-omics da

An upgraded computational tool from St. Jude Children’s Research Hospital can find potentially druggable hidden drivers of cancer and other biological processes using multi-omics data.

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence - Vimarsana News

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

Rhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.